Trial Profile
Efficacy and Safety of Morning Versus Evening Intake of Simvast CR Tablet in Patients With Hyperlipidemia: A Randomized, Double-blind, Multicenter Phase 3 Trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 29 Aug 2013 Results published in the Clinical Therapeutics.
- 29 Aug 2013 Primary endpoint 'LDL-cholesterol-level' has been met.
- 12 Sep 2009 New trial record